Effects of ivabradine for the ventricular rate control in patients with permanent atrial fibrillation and heart failure

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20160706002

Enrollment

Unknown

Registered

2016-07-06

Start date

2015-02-05

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrilation Atrial Fibrilation&#44

Interventions

Ivabradine,Placebo

Active Comparator Drug,Placebo Comparator Drug

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age >18 year 2. Patient with permanent AF 3. Resting Ventricular rate > or = 70 bpm as measured on 6 second rhythm strip

Exclusion criteria

Exclusion criteria: 1. presence of third-degree AV or significant sinus node disease 2. Unwilling to give informed consent

Design outcomes

Primary

Measure	Time frame
mean ventricular rate 1 month Holter	—

Secondary

Measure	Time frame
à¹ŒN/A N/A N/A	—

Contacts

Public ContactWanwarang Wongcharoen

Chiang Mai university

bwanwarang@yahoo.com053936716

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026